Cancer News and Research

Latest Cancer News and Research

Elsevier assumes publication of Neoplasia and Translational Oncology journals

Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, has announced that it has acquired Neoplasia Press Inc. and assumes publication of its flagship journals, Neoplasia and Translational Oncology. These peer-reviewed, open access journals are now published by Elsevier under the Neoplasia Press imprint.

6 Jan 2015

Brazilian researchers find that nutrition education may help prevent reoccurrence of breast cancer

Breast cancer is the most frequent cause of death among women worldwide, and five-year survival rates are just 58.4% in Brazil, lower than in many other regions. In a new study, however, researchers from Federal University of Santa Catarina provided Brazilian breast cancer patients with nutrition education and found it could benefit patients and may help prevent reoccurrence of the cancer.

6 Jan 2015

Many breast cancer patients undergoing lumpectomy surgery benefit from new intra-operative technology

Many patients undergoing lumpectomy surgery at NYU Langone Medical Center for the removal of an early detected breast tumor - the surgical option of choice for this diagnosis -- are benefitting from new intra-operative technology that detects microscopic amounts of cancer cells on removed tumor tissue not visible during or following surgical intervention.

6 Jan 2015

LEO Pharma submits NDA for aerosol foam formulation to treat patients with plaque psoriasis

LEO Pharma announces it has submitted a New Drug Application (NDA) for calcipotriene and betamethasone dipropionate aerosol foam, 0.005%/0.064%, to the U.S. Food and Drug Administration (FDA) for the treatment of plaque psoriasis.

6 Jan 2015

Johns Hopkins scientists use genome editing technology to alter human stem cells

A powerful “genome editing” technology known as CRISPR has been used by researchers since 2012 to trim, disrupt, replace or add to sequences of an organism’s DNA.

6 Jan 2015

Low alcohol consumption, plant-based diet reduce risk of obesity-related cancers

Low alcohol consumption and a plant-based diet, both healthy habits aligning with current cancer prevention guidelines, are associated with reducing the risk of obesity-related cancers, a New York University study shows.

6 Jan 2015

Seattle Cancer Care Alliance launches health improvement grant program

Inspired by its Community Health Needs Assessment (CHNA) 2012-2015 report, Seattle Cancer Care Alliance recently launched a health improvement grant program. The new community program addresses specific cancer screening, early detection, and prevention needs for at risk populations in King, Snohomish, and Pierce counties.

6 Jan 2015

ANSTO launches nuclear medicine program to improve diagnosis, treatment of cancer and heart disease

You can’t see it, hear it or smell it, and it’s constantly changing: but despite that, Australia’s nuclear scientists have figured out how to more accurately measure the unit of activity for radionuclides, the Becquerel (Bq).

6 Jan 2015

Oncoceutics, MD Anderson partner to develop novel anti-cancer drug

Oncoceutics Inc. and The University of Texas MD Anderson Cancer Center today announced the initiation of a strategic alliance and research collaboration agreement for the clinical development of ONC201, a novel anti-cancer drug.

5 Jan 2015

Holding breath during radiation therapy can reduce radiation exposure to the heart

Women who have breast cancer on their left side present a particular challenge to radiation oncologists. Studies have shown that the risk of heart disease is higher in this group of women after radiation treatment because it can be difficult to ensure that a sufficient dose of radiation is delivered to the left breast while adequately shielding the heart from exposure.

5 Jan 2015

Sirnaomics submits STP705 IND Application to CFDA for skin scar treatment

Sirnaomics, Inc. and its affiliate Suzhou Sirnaomics Pharmaceutics, Co. Ltd., together with its partner Guangzhou Xiangxue Pharmaceutical, Co. Ltd., (SZSE: 300147), have formally submitted an Investigational New Drug (IND) Application to the China Food and Drug Administration for STP705, an anti-fibrosis RNA interference (RNAi) therapeutic for prevention and treatment of human skin hypertrophic scars.

5 Jan 2015

Saatchi Bill: an interview with Dr. David Collingridge, Editor-in-Chief, The Lancet Oncology

The intention of the Medical Innovation Bill is to encourage and support doctors to explore new medicines for their patients when they believe existing options are no longer achieving good outcomes.

4 Jan 2015

Luck is a key factor in cancer development

A statistical model that measures the proportion of cancers that develop as a result of random mutations occurring during cell division was published in Science today.

2 Jan 2015

New imaging technology to detect cancer during surgery moves a step closer to market

New imaging technology that for the first time enables surgeons to detect cancer in real time during operations has moved a step closer to market thanks to a £2m ($3.1m) funding round by UK medical device company Lightpoint Medical.

2 Jan 2015

Johns Hopkins scientists create statistical model to measure proportion of cancer incidence

Scientists from the Johns Hopkins Kimmel Cancer Center have created a statistical model that measures the proportion of cancer incidence, across many tissue types, caused mainly by random mutations that occur when stem cells divide.

2 Jan 2015

Adding Tomosynthesis to standard mammography improves breast cancer screening, reduces radiation level

Dr. Lisa Weinstock, Director of Women's Digital Imaging in Ridgewood, said she has added Hologic Low-Dose 3-D Mammography (Breast Tomosynthesis) with C-View 2-D Imaging to enhance breast cancer screening of patients.

2 Jan 2015

UT Southwestern researchers target cells' biological clock to kill cancer cells, shrink tumor growth

Cell biologists at UT Southwestern Medical Center have targeted telomeres with a small molecule called 6-thiodG that takes advantage of the cell's 'biological clock' to kill cancer cells and shrink tumor growth.

2 Jan 2015

Breast cancer risk for women with atypical hyperplasia greater than previously thought, study finds

Women with atypical hyperplasia of the breast have a higher risk of developing breast cancer than previously thought, a Mayo Clinic study has found. Results of the study appear in a special report on breast cancer in the New England Journal of Medicine.

2 Jan 2015

New treatment approach may improve survival rates for certain patients with stage 4 lung cancer

A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, UT Southwestern Medical Center cancer researchers report.

2 Jan 2015

Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

Immunotherapy, genomic profiling, and investigating game-changing drug therapies topped the list of most important cancer research and clinical developments at Dana-Farber Cancer Institute in 2014.

1 Jan 2015

Cancer News and Research

Latest Cancer News and Research

Elsevier assumes publication of Neoplasia and Translational Oncology journals

Brazilian researchers find that nutrition education may help prevent reoccurrence of breast cancer

Many breast cancer patients undergoing lumpectomy surgery benefit from new intra-operative technology

LEO Pharma submits NDA for aerosol foam formulation to treat patients with plaque psoriasis

Johns Hopkins scientists use genome editing technology to alter human stem cells

Low alcohol consumption, plant-based diet reduce risk of obesity-related cancers

Seattle Cancer Care Alliance launches health improvement grant program

ANSTO launches nuclear medicine program to improve diagnosis, treatment of cancer and heart disease

Oncoceutics, MD Anderson partner to develop novel anti-cancer drug

Holding breath during radiation therapy can reduce radiation exposure to the heart

Sirnaomics submits STP705 IND Application to CFDA for skin scar treatment

Saatchi Bill: an interview with Dr. David Collingridge, Editor-in-Chief, The Lancet Oncology

Luck is a key factor in cancer development

New imaging technology to detect cancer during surgery moves a step closer to market

Johns Hopkins scientists create statistical model to measure proportion of cancer incidence

Adding Tomosynthesis to standard mammography improves breast cancer screening, reduces radiation level

UT Southwestern researchers target cells' biological clock to kill cancer cells, shrink tumor growth

Breast cancer risk for women with atypical hyperplasia greater than previously thought, study finds

New treatment approach may improve survival rates for certain patients with stage 4 lung cancer

Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in